1. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 2003;170(2 Pt 1):530-47. PMID:
12853821
3. Park SK, Sakoda LC, Kang D, Chokkalingam AP, Lee E, Shin HR, et al. Rising prostate cancer rates in South Korea. Prostate 2006;66:1285-91. PMID:
16741923
7. Robert G, Descazeaud A, Azzouzi R, Saussine C, Haillot O, Dumonceau O, et al. Impact of lower urinary tract symptoms on discomfort in men aged between 50 and 80 years. Urol Int 2010;84:424-9. PMID:
20339294
8. Kojima M, Naya Y, Inoue W, Ukimura O, Watanabe M, Saitoh M, et al. The American Urological Association symptom index for benign prostatic hyperplasia as a function of age, volume and ultrasonic appearance of the prostate. J Urol 1997;157:2160-5. PMID:
9146607
9. Kojima M, Ochiai A, Naya Y, Ukimura O, Watanabe M, Watanabe H. Correlation of presumed circle area ratio with infravesical obstruction in men with lower urinary tract symptoms. Urology 1997;50:548-55. PMID:
9338730
10. Kurita Y, Masuda H, Terada H, Suzuki K, Fujita K. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia. Urology 1998;51:595-600. PMID:
9586613
11. Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 1993;186:509-13. PMID:
7678467
12. Neumaier CE, Martinoli C, Derchi LE, Silvestri E, Rosenberg I. Normal prostate gland: examination with color Doppler US. Radiology 1995;196:453-7. PMID:
7617860
13. Bulut S, Ozden C, Aktas BK, Deren T, Tagci S, Gokkaya CS, et al. Effects of medical therapy or surgery on prostatic and bladder resistive indices in patients with benign prostatic hyperplasia. Urol Int 2015;94:181-6. PMID:
25139617
14. Shinbo H, Kurita Y. Application of ultrasonography and the resistive index for evaluating bladder outlet obstruction in patients with benign prostatic hyperplasia. Curr Urol Rep 2011;12:255-60. PMID:
21475953
15. Tsuru N, Kurita Y, Masuda H, Suzuki K, Fujita K. Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy. Int J Urol 2002;9:427-30. PMID:
12225338
16. Amiel GE, Slawin KM. Newer modalities of ultrasound imaging and treatment of the prostate. Urol Clin North Am 2006;33:329-37. PMID:
16829268
17. Nelson TR, Pretorius DH. The Doppler signal: where does it come from and what does it mean? AJR Am J Roentgenol 1988;151:439-47. PMID:
2970215
18. Ozdemir H, Onur R, Bozgeyik Z, Orhan I, Ogras MS, Ogur E. Measuring resistance index in patients with BPH and lower urinary tract symptoms. J Clin Ultrasound 2005;33:176-80. PMID:
15856514
19. Hayami S, Ushiyama T, Kurita Y, Kageyama S, Suzuki K, Fujita K. The value of power Doppler imaging to predict the histologic components of benign prostatic hyperplasia. Prostate 2002;53:168-74. PMID:
12242732
20. Kojima M, Watanabe H, Watanabe M, Okihara K, Naya Y, Ukimura O. Preliminary results of power Doppler imaging in benign prostatic hyperplasia. Ultrasound Med Biol 1997;23:1305-9. PMID:
9428128
21. Ozden C, Gunay I, Deren T, Bulut S, Ozdal OL, Koparal S, et al. Effect of transurethral resection of prostate on prostatic resistive index. Urol Int 2010;84:191-3. PMID:
20215824
22. Zhang X, Li G, Wei X, Mo X, Hu L, Zha Y, et al. Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia. J Urol 2012;188:881-7. PMID:
22819411
23. Berger AP, Horninger W, Bektic J, Pelzer A, Spranger R, Bartsch G, et al. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease? BJU Int 2006;98:587-90. PMID:
16796699